Liminatus pharma inc. evaluates formation of digital asset investment vehicle targeting up to $500 million in capital strategies

Strategic internal review initiated for treasury diversification through a prospective digital asset subsidiary — no entity formed, no capital committed strategic internal review initiated for treasury diversification through a prospective digital asset subsidiary — no entity formed, no capital committed
LIMN Ratings Summary
LIMN Quant Ranking